Study: NCT02345928

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1: CNTO 7160
Description: Participants will receive Drug CNTO7160 administered IV infusion at escalating doses (with a starting dose of 0.001 mg/kg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1: CNTO 7160
Description: Participants will receive Drug CNTO7160 administered IV infusion at escalating doses (with a starting dose of 0.001 mg/kg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1: CNTO 7160
Description: Participants will receive Drug CNTO7160 administered IV infusion at escalating doses (with a starting dose of 0.001 mg/kg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1: CNTO 7160
Description: Participants will receive Drug CNTO7160 administered IV infusion at escalating doses (with a starting dose of 0.001 mg/kg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1: CNTO 7160
Description: Participants will receive Drug CNTO7160 administered IV infusion at escalating doses (with a starting dose of 0.001 mg/kg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1: CNTO 7160
Description: Participants will receive Drug CNTO7160 administered IV infusion at escalating doses (with a starting dose of 0.001 mg/kg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1: CNTO 7160
Description: Participants will receive Drug CNTO7160 administered IV infusion at escalating doses (with a starting dose of 0.001 mg/kg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1: CNTO 7160
Description: Participants will receive Drug CNTO7160 administered IV infusion at escalating doses (with a starting dose of 0.001 mg/kg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1: CNTO 7160
Description: Participants will receive Drug CNTO7160 administered IV infusion at escalating doses (with a starting dose of 0.001 mg/kg).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 2 (Asthma): CNTO 7160
Description: Participants will receive Drug CNTO 7160 administered IV infusions (3 dose administrations over 4 weeks).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 2 (Asthma): CNTO 7160
Description: Participants will receive Drug CNTO 7160 administered IV infusions (3 dose administrations over 4 weeks).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 2 (Atopic Dermatitis): CNTO 7160
Description: Participants will receive Drug CNTO 7160 administered IV infusions (3 dose administrations over 4 weeks).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 2 (Atopic Dermatitis): CNTO 7160
Description: Participants will receive Drug CNTO 7160 administered IV infusions (3 dose administrations over 4 weeks).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1 and Part 2: Placebo
Description: Participants will receive single IV infusion of placebo matched to CNTO 7160.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1 and Part 2: Placebo
Description: Participants will receive single IV infusion of placebo matched to CNTO 7160.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1 and Part 2: Placebo
Description: Participants will receive single IV infusion of placebo matched to CNTO 7160.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1 and Part 2: Placebo
Description: Participants will receive single IV infusion of placebo matched to CNTO 7160.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1 and Part 2: Placebo
Description: Participants will receive single IV infusion of placebo matched to CNTO 7160.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1 and Part 2: Placebo
Description: Participants will receive single IV infusion of placebo matched to CNTO 7160.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1 and Part 2: Placebo
Description: Participants will receive single IV infusion of placebo matched to CNTO 7160.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1 and Part 2: Placebo
Description: Participants will receive single IV infusion of placebo matched to CNTO 7160.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1 and Part 2: Placebo
Description: Participants will receive single IV infusion of placebo matched to CNTO 7160.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1 and Part 2: Placebo
Description: Participants will receive single IV infusion of placebo matched to CNTO 7160.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1 and Part 2: Placebo
Description: Participants will receive single IV infusion of placebo matched to CNTO 7160.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1 and Part 2: Placebo
Description: Participants will receive single IV infusion of placebo matched to CNTO 7160.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Part 1 and Part 2: Placebo
Description: Participants will receive single IV infusion of placebo matched to CNTO 7160.